Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916) | Zendy

Leili Safdarian | Zendy; F. S. Mohammadi | Zendy; Ashraf Alleyassin | Zendy; Marzieh Aghahosseini | Zendy; Alipasha Meysamie | Zendy; E Rahimi | Zendy

Open Access

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)

Author(s) -

Leili Safdarian,

F. S. Mohammadi,

Ashraf Alleyassin,

Marzieh Aghahosseini,

Alipasha Meysamie,

E Rahimi

Publication year - 2007

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem223

Subject(s) - buserelin , triptorelin , medicine , embryo transfer , randomized controlled trial , clinical trial , double blind , intracytoplasmic sperm injection , stimulation , gynecology , infertility , surgery , gonadotropin releasing hormone , embryo , pregnancy , biology , luteinizing hormone , hormone , placebo , pathology , genetics , receptor , agonist , alternative medicine , microbiology and biotechnology

Traditional doses of depot GnRH agonist may be excessive for ovarian stimulation. We compared half-dose depot triptorelin (Group I) with reduced-dose daily buserelin (Group II) in a long protocol ICSI/embryo transfer through a double-blind randomized clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research